Breast cancer drug ALERT: Seasoned medical writer Dr. Vernon Coleman CONDEMNS ZOLADEX saying it’s dangerous, ineffective and misused

In quite the dogmatic critique, Dr. Vernon Coleman, a long-time medical writer and critic of conventional drug protocols, has called out the breast cancer drug Zoladex (goserelin) as dangerous, ineffective, and misused. Writing from a personal perspective informed by years of research into pharmaceutical side effects, Coleman denounces Zoladex as not only ineffective in improving outcomes for breast cancer patients but also as carrying a staggering list of severe and underreported adverse effects.

• No Proven Benefit from Zoladex in Breast Cancer Treatment: A meta-analysis of four controlled trials involving 6,279 patients found that combining Zoladex (goserelin) with tamoxifen in premenopausal women showed no improvement in disease-free or overall survival, raising serious doubts about its medical justification.
• Severe and Extensive Side Effects of Zoladex: Common and very common side effects listed by NICE include heart attack, heart failure, spinal cord compression, depression, diabetes and neoplasm complications. The drug also increases blood sugar, potentially accelerating cancer growth.
• Concerns About Administration and Oversight: Zoladex is administered via deep abdominal injections with large needles, often by undertrained staff in non-hospital settings, adding physical and psychological risks to its already questionable profile.
• Expert Criticism and Patient Caution: Vernon Coleman strongly condemns the drug as “one of the most evil and misappropriately prescribed,” urging cancer patients to critically evaluate their treatment options and reject unnecessary, harmful medications.

Drugs used to treat breast cancer have no benefit, only side effects, claims doctor

Zoladex is a hormone therapy drug used to treat breast and prostate cancers, as well as conditions like endometriosis and abnormal uterine bleeding. It suppresses the body’s production of sex hormones, particularly estrogen and testosterone. It is often administered alongside tamoxifen, a more commonly known breast cancer medication. Tamoxifen itself is a hormone-blocking drug used to prevent cancer recurrence, particularly in premenopausal women.

Dr. Coleman recounts his experience with a patient named Antoinette, who was advised by her oncologist to begin Zoladex injections six months after breast cancer surgery. At the time, she was already taking tamoxifen. Concerned about the administration of Zoladex — especially via deep abdominal injections potentially delivered by undertrained staff — Dr. Coleman investigated the medical literature for its benefits and risks.

What he found, he says, was alarming. A meta-analysis of four clinical trials involving 6,279 women concluded that combining Zoladex with tamoxifen provided no additional benefit in terms of disease-free or overall survival. In short, the treatment had no measurable impact on prolonging life or preventing cancer recurrence in premenopausal women.

Given the lack of therapeutic advantage, Dr. Coleman argues that the drug would need to be virtually side-effect free to justify its use. However, Zoladex is far from that. According to the British National Formulary, its common or very common side effects include: hair loss, joint pain, bone pain, depression, heart failure, diabetes, impaired glucose tolerance, mood alterations, hot flushes, heart attack, spinal cord compression, skin reactions, sexual dysfunction, and weight gain, among many others.

Coleman highlights the disturbing fact that many drug side effects go unreported by doctors, with estimates suggesting that fewer than 10 percent are documented — and in the U.S., possibly as low as 1 percent. Among the most troubling side effects of Zoladex is its tendency to raise blood sugar levels, a serious issue considering that cancer cells feed on sugar.

Dr. Coleman concludes that Zoladex is one of the most harmful and unnecessarily prescribed drugs he has ever studied. He even likens using it to drinking bleach, saying it’s something he wouldn’t even use as a drain cleaner. Compared to Zoladex, he considers tamoxifen “as safe as jam.”

The central message of Coleman’s essay is a warning to cancer patients to actively question their treatment plans and not to blindly follow medical recommendations, especially when those recommendations involve drugs with severe side effects and questionable efficacy.

Tune your internet dial to NaturalMedicine.news for tips on how to use natural remedies for preventative medicine and for healing, instead of succumbing to Big Pharma products that cause, spread, and exacerbate disease and disorder, including breast cancer.

Sources for this article include:

NaturalNews.com

Expose-news.com

MY.ClevelandClinic.org

DovePress.com